Explore more publications!

Middle East Business Channel: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Business Channel.

Press releases published on October 8, 2025

AmiViz Partners with Corgea to Strengthen Code Security Across the Middle East
Longevity Expert Establishes a New Benchmark in Consciousness Detection - New Future for Brain-Computer Interfaces?
Blockchain Life 2025 in Dubai – The Legendary Akon will Perform an Exclusive Set at the Official Afterparty
From Passion to Investment: How Collectible Watches Are Outperforming Traditional Assets
Global Automotive Blockchain Market Valued at $428.57 Million in 2020, Expected to Hit $5.61 Billion by 2030
TierOne to Showcase NaaS CX, Smart NOC, and NaaS NOC Solutions at GITEX 2025
IPQS Launches Enterprise Fintech Solutions & Partnerships
Ground Support Equipment Market Size Expected to Reach $14.2 Billion by 2032
Digital Zone Explores New Partnerships at HITEX 2025
New Investment Arm ZavoVentures by ZavoMedia PR Group Champions Female-Led Startup Success with Dedicated PR Support
Globaliser Announces Hermes Cache Pro: Multi-Location In-Memory Cache Globally for WordPress & WooCommerce
Nilo Therapeutics se lanza con un financiamiento Serie A de 101 millones de dólares para avanzar una nueva clase de medicamentos dirigidos a los circuitos neuronales en enfermedades inmunológicas y nombra a Kim Seth como director ejecutivo
Lancement de Nilo Therapeutics avec un financement de série A de 101 millions de dollars en vue de développer une nouvelle classe de médicaments ciblant les circuits neuronaux dans les maladies immunitaires, et nomination de Kim Seth au poste de…
ナイロ・セラピューティクス (Nilo Therapeutics)、免疫疾患における神経回路を標的とする新しい種類の医薬品開発を推進するため、1億100万米ドル (約154億1,290万円) のシリーズA資金調達を実施し、キム・セス博士 (Kim Seth, Ph.D.) を最高経営責任者 (CEO) に任…
Nilo Therapeutics dilancarkan dengan pembiayaan Siri A sebanyak $101 juta untuk membangunkan kelas baharu ubat-ubatan yang menyasarkan litar neural dalam penyakit imun, serta melantik Kim Seth sebagai Ketua Pegawai Eksekutif
Nilo Therapeutics é lançada com financiamento de US $101 milhões da Série A para promover uma nova classe de medicamentos direcionados a circuitos neurais em doenças imunológicas e nomeia Kim Seth como CEO
Nilo Therapeutics 啟動 1.01 億美元 A 輪融資,推進針對免疫疾病神經迴路的新型藥物研發,並任命 Kim Seth 為行政總裁
Nilo Therapeutics เปิดตัวด้วยการระดมทุนรอบ Series A มูลค่าถึง 101 ล้านเหรียญสหรัฐ เพื่อพัฒนายาประเภทใหม่ที่มุ่งเป้าไปที่วงจรระบบประสาทในโรคภูมิคุ้มกัน รวมถึงแต่งตั้ง Kim Seth เป็นประธานเจ้าหน้าที่บริหา…
Nilo Therapeutics 启动 1.01 亿美元 A 轮融资,以推进靶向免疫疾病神经回路的新型药物研发,并任命 Kim Seth 为首席执行官
AppFolio Data Breach Exposes Personal Information: Murphy Law Firm Investigates Legal Claims

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions